Since the start of the year NanoEcho has reached several milestones. The company has carried out a new share issue on a post money valuation of SEK 127,577,000, after raising 17,500,000 SEK. We estimate that this is more than enough to finance the company until the next capital acquisition planned in connection with the IPO before the end of the year.
With both financing and a very strong board of directors, NanoEcho has been able to attract qualified personnel for the operational operations of the company. The development of a beta prototype for preclinical studies is proceeding at the desired speed and success.
– I am absolutely convinced that the combination of my enthusiasm, long history in medical technology and the experience of successfully taking products from the idea stage to successful launches, will bring NanoEcho to a great success, says NanoEcho’s incoming CEO Linda Persson.
NanoEcho is a Swedish company developing pioneering technology where nanoparticles are used as contrast agents for medical ultrasound imaging.